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Background: Peripheral nerve injuries can trigger neuropathic pain in adults but cause little or no pain when they
are sustained in infancy or early childhood. This is confirmed in rodent models where neonatal nerve injury causes
no pain behaviour. However, delayed pain can arise in man some considerable time after nerve damage and to
examine this following early life nerve injury we have carried out a longer term follow up of rat pain behaviour into
adolescence and adulthood.
Results: Spared nerve injury (SNI) or sham surgery was performed on 10 day old (P10) rat pups and mechanical
nociceptive reflex thresholds were analysed 3, 7, 14, 21, 28, 38 and 44 days post surgery. While mechanical thresholds on
the ipsilateral side are not significantly different from controls for the first 2–3 weeks post P10 surgery, after that time
period, beginning at 21 days post surgery (P31), the SNI group developed following early life nerve injury significant
hypersensitivity compared to the other groups. Ipsilateral mechanical nociceptive threshold was 2-fold below that of
the contralateral and sham thresholds at 21 days post surgery (SNI-ipsilateral 28 (±5) g control groups 69 (±9) g, p< 0.001,
3-way ANOVA, n= 6 per group). Importantly, no effect was observed on thermal thresholds. This hypersensivity was
accompanied by macrophage, microglial and astrocyte activation in the DRG and dorsal horn, but no significant change
in dorsal horn p38 or JNK expression. Preemptive minocycline (daily 40 mg/kg, s.c) did not prevent the effect. Ketamine
(20 mg/kg, s.c), on the other hand, produced a dose-dependent reversal of mechanical nociceptive thresholds ipsilateral
to the nerve injury such that thresholds return to control levels at the highest doses of 20 mg/Kg.
Conclusions: We report a novel consequence of early life nerve injury whereby mechanical hypersensitivity only emerges
later in life. This delayed adolescent onset in mechanical pain thresholds is accompanied by neuroimmune activation and
NMDA dependent central sensitization of spinal nociceptive circuits. This delayed onset in mechanical pain sensitivity may
provide clues to understand the long term effects of early injury such as late onset phantom pain and the emergence of
complex adolescent chronic pain syndromes.
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It is well documented that neuropathic pain is absent or
transient in the youngest infants or children. Brachial plexus
injuries at birth, followed by nerve repair, are not associated
with pain [1] and reports of phantom pain, complex
regional pain syndrome, peripheral neuropathy pain are
very rare before 5–6 years of age [2]. This is supported by
animal models of neuropathic pain, spared nerve injury
(SNI) and chronic constriction injury (CCI), where little or* Correspondence: david.vega74@gmail.com
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distribution, and reproduction in any mediumno allodynia and pain behaviour is observed in animals
whose nerves have been injured before three weeks of age
or postnatal day 21 (P21) [3-5].
The aim of the current study was to investigate the longer
term effects of early nerve injury and to test whether pain or
hypersensitivity might emerge beyond the post injury period,
perhaps only in adolescence. To date, the longer term effects
of nerve injury, and the possibility of emergence of pain be-
yond childhood has not specifically been addressed [6-8].
Most studies of nerve injury in infants have not followed up
the long term consequences; obstetric injuries in man have
been followed up for only for about 7 years and experimental
nerve injury rat pups, only for a few weeks [5]. Intriguing
clues exist in the clinical literature that symptoms mayentral Ltd. This is an Open Access article distributed under the terms of the
creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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studied phantom limb pain in adolescents with either con-
genital or early surgical loss of limbs, they noted that onset
of phantoms in those with the earliest loss were remarkably
delayed – emerging only after a mean of 7 years [9]. The
possibility that nerve injury in childhood could cause a
delayed onset pain syndromes is interesting in view of the
onset of unexplained pain syndromes such as complex re-
gional pain syndrome (CRPS) in adolescence [10].
We have carried out a longitudinal study of pain be-
haviour and immune responses into adulthood, following
“spared nerve injury” (SNI) in young rats. We have
observed that while young rats fail to display neuropathic
behaviour for the first weeks after nerve injury, at adoles-
cence they develop lasting cutaneous mechanical hyper-
sensitivity as a consequence of this early-life nerve injury.
Materials and methods
Surgery
Surgery was performed on adult (8 weeks old) male
Sprague–Dawley rats and rat male pups (10 days postna-
tal age, P10) and carried out in accordance with the
United Kingdom Animal (Scientific Procedures) Act
1986. Spared nerve injury (SNI) and sham surgery were
performed under (4 %) halothane general anaesthesia
with antiseptic conditions as described previously [11].
After skin preparation, the sciatic nerve and its three ter-
minal branches were exposed in the upper lateral thigh.
The common peroneal and tibial branches were cut and
ligated under direct vision, leaving the sural nerve intact.
Muscle and skin were closed in two layers. In sham
operations, the procedures were the same but the nerves
were only exposed and not cut or ligated. In all cases
great care was taken neither to stretch the nerve or its
branches nor to damage the intact nerves.
After surgery, animals were returned to their cages and
litters and maintained on a 12 hour light/dark cycle at
constant ambient temperature with free access to food




Rats that had undergone spared nerve injury (SNI) or
sham surgery at P10 were tested for cutaneous mechanical
sensitivity at 3, 7, 14, 21, 28, 38 and 44 days post surgery
(n= 6 per group). Flexion withdrawal reflex thresholds in
response to punctate mechanical stimulation of the dorso-
lateral surface of the hindpaw was tested using calibrated
von Frey filaments (VF), that exert a reproducible stimulus
strength in grams (Stoelting, Woodvale, IL). The dorsolat-
eral surface of the hindpaw is innervated by the sural
nerve, and this test is known to reveal mechanical allody-
nia in the adult rat after SNI surgery [11]. Filaments wereapplied sequentially to the plantar surface of the hind paw
six times at intervals of 1 s. Response threshold was
defined as the VF filament which produced reflex paw
withdrawal in 4 out of 6 applications.
Thermal pain thresholds
Rats that had undergone spared nerve injury (SNI) or
sham surgery P10, were also tested for thermal cutane-
ous sensitivity at 3, 7, 14, 21, 35, 45 and 51 days post sur-
gery (n = 6 per group). The lateral plantar surface was
exposed to a beam of radiant heat through a transparent
Perspex surface (Hugo Basile Inc.) [12]. The flexion with-
drawal reflex latency was recorded, with a minimal value
of 0.5 s and a maximum of 15 s. The heat stimulation
was repeated 3 times at an interval of 5–10 min for each
paw and the mean calculated.
Minocycline administration
Rat pups (n= 6) received a 40 mg/kg i.p. minocycline, a
dose which reverses mechanical allodynia after nerve injury
in adults [13]. The first injection was administered the day
before (P9) SNI surgery, the second just prior to surgery at
P10 and this was followed by daily ip injections of minocy-
cline until 21 days post surgery (P31). Two control groups
were used (i), a group of SNI animals injected with saline
(n= 6), and (ii) a group of sham surgery animals, injected
with either saline (n=6) or minocycline (n= 6). The ani-
mals were tested for mechanical pain thresholds using cali-
brated von Frey hairs. The test was carried out by a blinded
observer: the animals were tagged with a chip applied sub-
cutaneously to avoid any identifiable external marks and
the animals were given to the observer in a random order.
The data was collected for analysis by ANOVA.
Ketamine administration
Young adult rats (P31) that had undergone SNI (n = 6)
or sham (n = 6) surgery at P10 were treated with sub-
cutaneous ketamine (Sigma) in cumulative doses of 1, 10
and 20 mg/Kg in a volume of 250 μl as described else-
where [14]. Doses were administered at intervals of one
hour. Two methods were used: 1) Change in response
frequency to a threshold mechanical stimulus, where the
frequency of paw withdrawal before and after ketamine
injection in response to the same, threshold von Frey
hair applied to the dorsolateral area of the paw, was
compared. The mean mechanical threshold was signifi-
cantly different in the ipsilateral SNI group (31 ± 6 g) and
the control groups (67 ± 4 g), (ANOVA p< 0.01, Tukey p
< 0.05). The data is expressed as a percentage of
responses to the corresponding baseline mechanical
threshold, plotted using average and standard error of the
mean and statistically analysed using a 2-way ANOVA. 2)
Change in mechanical pain thresholds measured with a
dynamic plantar aesthesiometer (Ugo Basile). Animals
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the aesthesiometer probe applied in the lateral plantar sur-
face of the paw within the territory innervated by the sural
nerve [11]. The intensity of the stimulus increased from 0
to 50 g in 30 seconds and the average threshold taken
from two applications. Mechanical sensitivity thresholds
were established before (baseline) and one hour after each
dose administration and a final measurement was per-
formed at 72 hours post ketamine administration (after
ketamine clearance).
Immunostaining
Tissue was extracted from rats that had undergone sur-
gery at P10 or as adults at 7 and 30 days (P10 only) post
surgery. Rats were overdosed with 100 mg/kg of Eutha-
nalW and perfused through the heart with 200 ml heparin-
saline, followed by 200 mL 4 % paraformaldehyde in 0.1 M
phosphate buffer (PB). The L4–L5 lumbar spinal cord and
the corresponding L4 and L5 ganglia were removed and
postfixed in 4 % paraformaldehyde for 1 h at 4°C followed
by immersion in 30 % sucrose in 0.1 M of PB at 4°C for at
least two days before sectioning. Serial, 20 μm cryostat
sections were cut and stained after blocking in 10 % nor-
mal goat serum, 0.3 % Triton X in 1× PBS using primary
antibodies: Rabbit anti-IBA-1 (1/1000, WakoW), mouse
anti NF200 (1/1000, ChemiconW), and rabbit-anti-GFAP
(1/100 DakoW). The antibodies were incubated overnight
at room temperature in 3 % normal goat serum, 0.3 % Tri-
ton X in 1× PBS. Secondary antibodies were goat anti-
mouse (Alexa-488W) and goat anti-rabbit (Alexa-593W) at
1/200 dilution in 3 % normal goat serum, 0.3 % Triton X
in 1× PBS. Antibody excess was removed by 3 washes in
PBS for 10′ at RT. The isolectin IB4 (Bandeira simplicifolia)
labelled with FITC (SigmaW) was used to identify the non-
peptidergic neurons [15]. After staining, the sections were
kept for 16 h in the dark to normalize the background and
then microscope images acquired at 10X magnification with
OpenLabW software at a constant exposure time of 1.0200.
The images generated by immunohistochemistry were
analysed with Image J 1.36 (NHS) software, n = 3 rats per
experimental group, n = 4-6 sections spinal cord or ganglia
per animal. In the spinal cord, microglia (IBA-1 positive;
[16] or astrocytes (GFAP positive; [17]) were counted in
the region of loss of IB4 staining, which delineates the area
of termination of lesioned nerve in the SNI model on the
ipsilateral and equivalent contralateral side [18]. Data is
expressed as fold difference of the contralateral side and
analysed using 2-way ANOVA and plotted using average
and standard error of the mean.
In the ganglion, sections were stained with IBA-1 to
label macrophages [19] and with NF200 to label large
neurons [20]. Representative sections from the centre of
the ganglion, 160 μm apart, were used for analysis. Macro-
phage activation was assessed as previously described [21],by counting neurons with enlarged macrophages and pro-
cesses clustering around the NF200+ve neuronal cell bod-
ies in characteristic 'ring-like' structures. Data was expressed
as percentage of large NF200 positive neurons with IBA-1
positive macrophage ring-like structures and analysed using
2-way ANOVA and plotted using average and standard
error of the mean.
Western-blot
The dorsal horn quadrant (ipsilateral or contralateral) of
L3–L5 spinal cord segments was snap frozen in liquid
nitrogen after extraction and stored at -80° C until fur-
ther procedure. Proteins were extracted in 150 μL RIPA
buffer (NP-40 1 %, Hepes 20 mM, pH 7.2, NaF 100 mM;
NaCl 100 mM, NaVO 1 mM, EDTA 5 mM, and 1 % of
protease inhibitor) from Sigma by blender homogenisa-
tion, incubated for 2 h on ice and centrifuged at 12,000 g
to remove the debris. The proteins were diluted to yield
1 mg/mL and stored in aliquots at -80° C. 10 μg of total
protein were used for the electrophoresis with the Mini
Protean 3 Cell System (Bio-Rad) with 10 % acrylamide
precast Ready gels (Bio-Rad). Electrophoresis was carried
out in Tris 20 mM, glycine 247 mM, and 0.0001 % SDS
buffer at 4° C until the reference colorant reached the
end of the gel. The Rainbow coloured protein ladder
from Amersham was loaded to monitor the electrophor-
esis. The transference blots to the PVDF membranes
(Bio-Rad) were done in Tris 48 mM, glycine 77 mM,
0.0001 % SDS, and 10 % of methanol for 1.5 h at 4° C.
Following the blot, membranes were blocked in PBS so-
lution (PBS tablets, Sigma) with 0.1 % Tween 20 (Sigma)
and 4 % semi-skimmed milk powder (Sainsbury’s). The
primary antibodies were incubated at 4° C overnight with
gentle shaking and diluted in blocking buffer (rabbit
anti-phospho-p38 or rabbit anti-phospho-JNK at 1:1000
from Cell Signaling and mouse anti-GAPDH from Chemi-
con at 1/2000). Secondary antibodies from Santa Cruz
were used at a dilution of 1/2000. Antibody excess was
removed with six washes in PBS/0.1 % Tween 20. To re-
veal the signal we used the ECL western blotting detection
system from Amersham and the images were acquired
with the Quantity One system (Bio-Rad). The intensity of
the western blots bands for phospho-p38 (~40 kDa), phos-
pho-JNK (~46 and ~54 Kda bans) and GFAP (~50 kDa)
were measured with Quantity One, v4.6.2 (Bio Rad) densi-
tometry using GAPDH (36 kDa band) housekeeping gene
for normalization. Values were expressed as the ratio
“densitometry protein/densitometry GAPDH”.
Results
Delayed adolescent onset of mechanical hypersensitivity
following early-life nerve injury
To analyse the long term consequences of early-life nerve
injury in pain behaviour we carried out a longitudinal study
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sham operations when they were 10 days old (P10).
Mechanical nociceptive reflex thresholds were analysed
3, 7, 14, 21, 28, 38 and 44 days post P10 surgery using
calibrated von Frey filaments (VF). As previously
reported [5], mechanical thresholds increase steadily
with increasing postnatal age in the control sham group
(ipsilateral and contralateral side) and on the unoperated
contralateral side of the SNI animals (Figure 1A), where
threshold rises from 18 (±2) g at P13 (3 days post sur-
gery) to 180 g at P54 (44 days post surgery). Figure 1A
shows mechanical thresholds on the ipsilateral side to
SNI surgery are not significantly different from controls
for the first 2–3 weeks post P10 surgery, in agreement
with previous studies [5]. However, Figure 1A also shows
that after that time period, beginning at 21 days post sur-
gery (P31), the SNI group developed a significantly
mechanical hypersensitivity compared to the other
groups. At 21 days post surgery, the ipsilateral mechan-
ical nociceptive threshold falls by 2-fold below that of
the contralateral and sham thresholds (SNI-ipsilateral
28 (±5) g control groups 69 (±9)g, p< 0.001, 3-way
ANOVA, n= 6 per group). By 28 days postsurgery (P38),
the SNI-ipsilateral threshold reaches a plateau of 56 (±6)
g, which is 1.7 fold lower than control groups and this
remains significantly lower by 1.9 fold and 3.3 fold at
P48 and P54 respectively; (p< 0.001, 3-way ANOVA,
Figure 1A).
Figure 1B shows the same longitudinal study on radi-
ant heat nociceptive thresholds, post P10 SNI surgery.
As reported elsewhere [22,23], thermal thresholds tend
to fall with postnatal age. However, in contrast to the ef-
fect on mechanical nociception, analysis of thermal noci-
ceptive thresholds shows no significant differences in
the SNI group when compared to the control groups
throughout the longitudinal study up to P54. (Figure 1B).Figure 1 Longitudinal changes in mechanical and thermal pain thresh
day (P) 10. A) Mechanical pain thresholds (sham group) increase with age
at the age of 10 days has no effect over the first 2–3 weeks but gradually i
ANOVA, p< 0.001; post hoc Tukey, p<p.05, n = 6 per experimental group).
in latency in all experimental groups with no significant differences in the SEarly-life nerve injury evokes a delayed adolescent onset
glial activation
In the light of the known relationship between glial acti-
vation and hyperalgesia [24-26], we analysed the time
course of activation of microglia and astrocytes in the
spinal cord and macrophages in dorsal root ganglia fol-
lowing early life nerve injury [27-29]. Glial activation was
examined in rats, which had undergone SNI surgery at
P10 rat pups, at two postnatal time points. The first was
at 7 days post surgery (P17), when there was no change
in mechanical sensitivity and the second was at 21 days
post surgery (P31) when mechanical hypersensitivity had
developed and both were compared with sham groups.
In addition, we included a group of rats that underwent
surgery as adults, 7 days post surgery as a positive con-
trol of glia activation [30].
Microglia
Figure 2 shows the effects of SNI surgery upon spinal
microglia activation. SNI surgery at P10 has no effect on
microglial activation in the lumbar dorsal horn 7 days
post surgery (P17), as reported previously [30,31], but at
21 days post surgery (P31) there is significant activation
of microglia in the dorsal horn, (p< 0.001, 2-way
ANOVA) (Figure 2A and 2B). Figure 2A shows the dis-
tribution of microglia (stained with the specific marker
IBA-1, in red) in the L4/L5 lumbar region of the spinal
cord. The depletion of isolectin IB4 (in green) from non-
peptidergic C-fibre terminals [32,33] delineates the ter-
mination area of lesioned nerves. The immunostaining
shows a clear increase in microglia cell numbers (prolif-
eration) ipsilateral to the nerve injury group compared
to control groups at 21 but not at 7 days post P10 sur-
gery (Figure 2A). Quantification of microglia staining
shows that 7 days post P10 surgery there is no significant
microglia activation when compared to the contrololds over 45 days following spared nerve injury (SNI at postnatal
as a consequence of the maturation of the pain pathway.Nerve injury
psilateral mechanical hypersensitivity emerges in adolescence (3-way
B) Thermal pain thresholds show a general developmental reduction
NI group when compared to sham group.
Figure 2 Changes in spinal microglia activation following spared nerve injury (SNI) at P10 and adult A) Shows sections through the L4
dorsal horn at various times after sham (top) and SNI (bottom) surgery at P10 (left and middle) and adult (right). Sections are immunostained with
the microglia marker IBA-1 (red) and the non peptidergic C-fibre marker isolectin IB-4 (green). SNI surgery at P10 produces non significant
microglia activation after 7 days compared to sham in (P10) rats. However, there is a late onset of microglia activation at 21 days post surgery
which is significantly greater than sham and similar to that seen in adult rats 7 days post surgery. The gap in isolectin IB-4 is a marker of the
terminal region of the nerves damaged by SNI surgery. B) Quantification of microglia activation in the three experimental groups illustrated in A.
IBA-1 stained microglial cells were counted and the results are expressed as fold difference of the contralateral side. *: (n = 3 animals per
experimental group, 3-way ANOVA, p< 0.001, Tukey, p< 0.05).
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cant increase (2.4 ±0.2 fold, p< 0.001, 2-way ANOVA) in
microglia activation comparable to that seen in adult
rats, post surgery (3.4 ±0.3) (Figure 2B). In the adult
injured group, microglia distribution is largely restricted
to the termination area of damaged afferents, as denoted
by the IB4 staining as reported elsewhere [34]. In con-
trast, delayed microglial activation following P10 nerve
injury was spread more widely throughout the whole ip-
silateral dorsal horn, at 21 days post surgery (Figure 2A).Astrocytes
Figure 3 shows the effects of surgery upon spinal astro-
cyte activation, using GFAP immunostaining to quantify
astrogliosis (increase in cell numbers with larger cell
bodies and processes) [17]. Figure 3A, shows that rats
that undergo SNI surgery at P10, show a clear increase
in GFAP immunoreactivity 21 days post surgery which is
not observed 7 days post surgery. Quantification of
GFAP immunoreactivity shows a significant (p< 0.001,
2-way ANOVA) increase (1.7 ±0.2 fold) in astrogliosis
Figure 3 Changes in spinal astrocyte activation following spared nerve injury (SNI) at P10 and adult. A). Shows sections through the L4
dorsal horn at various times after sham (top) and SNI (bottom) surgery at P10 (left and middle) and adult (right). Sections are immunostained with
the astrocytic marker GFAP (red) and the non peptidergic C-fibre marker isolectin IB-4 (green). SNI surgery at P10 produces non significant
astrocyte activation after 7 days compared to sham in (P10) rats. However, there is a late onset of astrocyte activation at 21 days post surgery
which is significantly greater than sham and similar to that seen in adult rats 7 days post surgery. The gap in isolectin IB-4 is a marker of the
terminal region of the nerves damaged by SNI surgery. B) Quantification of astrocyte activation in the three experimental groups illustrated in A.
GFAP stained astrocytes with signs of gliosis were counted and the results are expressed as fold difference of the contralateral side. *: (n = 3
animals per experimental group, 3-way ANOVA, p< 0.001, Tukey, p< 0.05).
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seen at 7 days. This pattern of astrocyte activation is
comparable to the astrogliosis observed after nerve in-
jury in adult rats (2.1 ± 0.1 fold) (Figure 3B).
Macrophages
Figure 4 shows the effects of surgery upon IBA-1 positive
macrophage activation in the dorsal root ganglion. Again,
at 7 days post P10 nerve injury there was no significant
change in macrophage distribution or morphology whencompared to control groups. In contrast, at 21 days post
P10 surgery, clear macrophage activation is observed,
where macrophages (in red) cluster around large neuronal
cell bodies in characteristic ‘ring-like’ structures with pro-
cesses extending from their enlarged cell bodies towards
large neurons (in green) (Figure 4A). Quantification of
these macrophage ring-like structures show a significant
(p< 0.001, 2-way ANOVA) increase at 21 days post sur-
gery (35 %± 3) but not at P17 (11 % ±3). This increase in
macrophage activation is below the 55 % ± 4 activation
Figure 4 Changes in dorsal root ganglia macrophage activation following spared nerve injury (SNI) at P10 and adult A). Shows sections
through the L4 dorsal root ganglion at various times after sham (top) and SNI (bottom) surgery at P10 (left and middle) and adult (right). Sections
are immunostained with the macrophage marker IBA-1 (red) and the large A cell neuronal population marker NF200 (green). Macrophage
activation is observed as macrophages clustering around large neuronal cell bodies in characteristic ‘ring-like’ structures with processes extending
from their enlarged cell bodies towards large neurons. SNI surgery at P10 produces non significant macrophage activation after 7 days compared
to sham in (P10) rats. However, there is a late onset of macrophage activation at 21 days post surgery which is significantly greater than sham
and similar to that seen in adult rats 7 days post surgery. B) Quantification of these activated macrophage ‘ring-like’ structures in the three
experimental groups illustrated in A and expressed as a percentage accordingly to large sensory neurons*: (n = 3 animals per experimental group,
3-way ANOVA, p< 0.001, Tukey, p< 0.05).
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(p< 0.001, 2-way ANOVA) greater than control groups
(2-3 %), (Figure 4B).
Minocycline fails to prevent adolescent mechanical
hypersensitivity produced by early-life nerve injury
To test whether late onset mechanical hypersensitivity
produced by P10 nerve injury is caused by delayed ado-
lescent onset of glia activation, we administered the
microglial inhibitor minocycline to sham and SNI rat
pups [13]. P10 rats underwent daily i.p. minocycline
(40 mg/kg) injections, beginning the day before SNI sur-
gery (P9), again immediately prior to SNI surgery at P10,
and then daily until 21 days post surgery (P31). Figure 5Ashows that at P31 there was no difference in the mech-
anical sensitivity of the SNI-minocycline (M) treated ani-
mals (16.1 ±4 g force) when compared to a SNI-saline
(S) treated group (14.6 ± 2.7 g force, Figure 5A). The
mechanical threshold was significantly lower in both
minocycline and saline SNI groups (ANOVA, p< 0.01;
Tukey, p< 0.05) than the sham group (H) (37.5 ± 2.1 g
force).
In adult models of nerve injury induced neuropathic
pain, microglial activation is accompanied by phosphor-
ylation of p38 and this is well known marker of microglia
activation after adult nerve injury [28]. Furthermore,
this phosphorylation of p38 after adult nerve injury is
known to be inhibited by minocycline [35,36]. However,
Figure 5 Minocycline fails to prevent the adolescent onset of mechanical hypersensitivity A). Mechanical pain thresholds in animals with
early-life (P10) nerve injury (S) or sham surgery H) tested in later life (P31). Mechanical pain thresholds were measured in minocycline (M) (40 mg/Kg
daily ip injections) after SNI nerve injury compared to SNI saline (S) group and controls (H). n = 6 per experimental group; *: ANOVA, p< 0.001, Tukey,
p< 0.05 B) Representative images of western-blot for phospho-p38 and phospho-JNK (pJNK) and the housekeeping gene Gapdh. Quantification was
done by densitometry of p38 (C) and pJNK(D). *: n = 4 per experimental group; *: ANOVA, p< 0.001, Tukey, p< 0.05.
Vega-Avelaira et al. Molecular Pain 2012, 8:30 Page 8 of 12
http://www.molecularpain.com/content/8/1/30interestingly, we did not find any differences in dorsal
horn phospho-p38 levels between the SNI-saline and
sham groups 21 days post surgery (P31), despite the
presence of activated microglia and behavioural hyper-
sensitivity (Figure 5). Figure 5 also shows the phospho-
p38 levels in SNI-minocycline treated animals are not
significantly different to the SNI-saline or sham groups
(Figure 5B and C).
We also analysed the phosphorylation of c-Jun N-
terminal kinase (JNK) which is a marker of astrocyte
activity after nerve injury and required for maintenance
of neuropathic pain [37,38]. We did not find any signifi-
cant difference when comparing the SNI-saline and
sham groups (Figure 5C and D) but minocycline had a
small (1.5 fold) but significant effect up on the SNI
group p< 0.001, 1-way RM-ANOVA, n = 4 per group).The NMDA antagonist ketamine reverses adolescent onset
mechanical hyperalgesia produced by early-life nerve
injury
To analyse whether the late adolescent onset mechanical
hypersensitivity is due to classic NMDA-dependent cen-
tral sensitization mechanisms [39], we tested the effect
of ketamine, the NMDA antagonist, upon the mechan-
ical hyperalgesia evoked by early life nerve injury. Rats
that underwent SNI surgery at P10 were tested 21 days
post surgery (P31) when they had developed clear and sig-
nificant differences in mechanical nociceptive thresholds.Figure 6A shows the effect of treatment with cumulative
doses of ketamine (0, 1, 10, 20 mg/kg, s.c) upon the mech-
anical hypersensitivity. The results show a clear dose-
dependent reversal of mechanical nociceptive thresholds
ipsilateral to the nerve injury (9 ±1, 10 ±1, 15 ±1 and
23 ±1 grams-force at 0, 1, 10 and 20 mg/Kg of ketamine
respectively) such that they reach control levels (26 ±1
grams-force) at the highest doses of 20 mg/Kg (Figure 6A).
The clearance of the ketamine (72 h after injection) elimi-
nates its effect and the thresholds fall again to 12 ±1
grams-force (Figure 6A).
The ability of ketamine to reduce mechanical hyper-
sensitivity was also measured using the frequency of paw
withdrawal threshold after mechanical noxious stimula-
tion with von Frey filaments (VF). The results show a
significant (p< 0.001, 3-way ANOVA, n = 6 per group)
reduction in the frequency of paw withdrawal at the
ketamine doses of 10 mg/Kg (to 52 % ±6) and 20 mg/Kg
(to 45 % ±11) (Figure 6B).
Ketamine had no effect on mechanical sensitivity
contralateral to the nerve injury or in the sham controls
in both tests (Figure 6A and 6B).Discussion
In this study we have analysed the long term conse-
quences of early-life nerve injury upon pain behaviour in
the rat. We have demonstrated for the first time that early
life nerve damage produces a mechanical hypersensitivity
Figure 6 Adolescent onset mechanical hypersensitivity is reversed by ketamine treatment A). Mechanical pain thresholds in animals with
early-life (P10) nerve injury (SNI-ipsi) or sham surgery (sham-ipsi) tested in later life (P31), before and after i.p ketamine. SNI surgery animals have
lower baseline mechanical pain thresholds but the NMDA antagonist ketamine increases mechanical pain thresholds to normal levels in a dose
dependant manner. The clearance of ketamine (72 h post injection) results in the mechanical pain thresholds falling back to pre-ketamine levels.
B) The same dose dependent reversal of mechanical hypersensitivity by ketamine is observed when measuring foot paw withdrawal to a von Frey
hair. *: (n = 6 per experimental group, 3-way ANOVA, p< 0.001, Tukey, p< 0.05), SNI: spared nerve injury, Ipsi: ipsilateral, Contra: contralateral, ip:
intraperitoneal, FPW: frequency of paw withdrawal. Ketamine had no effect upon contralateral (SNI-contra) thresholds or upon sham operated animals.
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and profound allodynic effects in adults [11,40], spared
nerve injury at postnatal day 10 has little or no effect upon
pain behaviour in the first weeks after surgery. However, if
threshold testing is extended to 3 weeks after the surgery,
a mechanical hypersensitivity on the ipsilateral hindpaw
emerges which is maintained into adult life. This hyper-
sensitivity was not observed on the contralateral paw or
following sham injury. Moreover, no differences were
observed in thermal nociceptive thresholds in these ani-
mals ruling out a non-specific motor deficit and suggesting
that early life spared nerve injury has a specific effect upon
adult mechanical nociception.
Mechanical pain thresholds steadily increase through
postnatal development due to fine tuning of spinal pain cir-
cuits [41] and the maturation of spinal inhibitory networks
[42]. This steady rise is also observed in animals after nerve
lesion [5] but only while the animal is still young. However,
at the onset of the adolescence, from P30 onwards [43], this
steady rise stops on the nerve injured side such that a sig-
nificant 2-fold decrease in mechanical pain thresholds
emerges leaving the adult animal with a selective mechan-
ical, but not thermal hypersensitivity on the affected side.
Clinically, there are few studies on the long term
effects of peripheral nerve injury in infants. While neuro-
pathic pain is not reported in young patients following
infant brachial nerve plexus avulsion [1,44], self-mutilation
is more frequent in these children [45] due to either the
subsequent post trauma surgery or the initial nerve injury
or both. Perhaps more relevant, it has been reported that
the appearance of phantom syndromes (many of which are
painful) following loss of limbs in infancy, do not appear
for many years after the original loss, in some cases up 3to 15 years later [9,46]. This delayed onset pain after early
nerve injury may also contribute to chronic complex pain
syndromes with cutaneous sensory abnormalities which
arise in adolescence, but whose aetiology is unknown
[10,47]. The animal model described here might cast some
light on such syndromes, revealing as it does, the possibil-
ity for hypersensitivity to arise a considerable time after an
original injury in infancy.
One possible mechanism underlying this emergence of
mechanical sensitivity might lie in the neuroimmune sys-
tem. Glial activation is a common characteristic of adult
neuropathies [25,26] and several studies have demon-
strated the need for microglial/macrophage activation to
initiate the neuropathy in the adult rodent [13,27,28].
We have previously demonstrated that there is little acti-
vation of either both spinal microglia [30,31] or macro-
phages in the dorsal horn [21] in the young P10 rat after
7 days post nerve injury and our recent transcriptome
analysis of the dorsal root ganglia and the dorsal horn at
different ages reveals a much greater and different profile
of immune related genes regulated in the adult com-
pared to young rats after nerve injury [21,48]. Since it is
well known that the immune system goes through dra-
matic changes of maturation through the postnatal de-
velopment [49,50], we hypothesized that a late onset
change in microglia/macrophage activation was the trig-
ger for the emergence of mechanical hypersensitivity in
adolescence. Consistent with this proposal, our results
showed that microglia, astrocytes and macrophages are
only activated after early life nerve injury at the onset of
the adulthood (at P30), the same time point at which
mechanical hypersensitivity emerges. However, import-
antly, microglial activation was not accompanied by an
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the adulthood (at P30) after early life nerve injury when
compared to the baseline levels of phosphorylation in the
sham operated group. While p38 phosphorylation is a key
event in microglia activation when the nerve injury is sus-
tained in adult animals[28], our results indicate that the
p38 map kinase pathway is not involved in this late onset
of microglia activation after early in life nerve injury. This
would explain why preemptive minocycline (a p38 inhibitor
[35,36]), at a dose designed to maximise its suppression of
macrophage/microglial activation [13] did not prevent or
even reduce the delayed onset adolescent mechanical
hypersensitivity.
It has been proposed that astrocytes have a key role in
the maintenance of neuropathic pain in adults [38] and
that microglia activation is required for the activation of
astrocytes [51,52]. Interestingly, we also observed astro-
gliosis at onset of adulthood (P30), but similarly to
microglia, we did not find differences in JNK phosphor-
ylation (a marker of astrocyte activation) at the onset of
the adulthood (at P30) after early life nerve injury when
compared to the baseline levels of phosphorylation in
the sham operated group. The small effect of minocy-
cline upon JNK phosphorylation was evidently not suffi-
cient to ameliorate the mechanical hyperalgesia.
Despite the rise in activation of microglia and astro-
cytes at the onset of the adulthood (at P30) after early
life nerve injury, our results suggest that this activation
must involve different signalling pathways to those clas-
sical map kinase pathways found when the injury is sus-
tained in the adulthood [28,37]. We cannot rule out the
possibility of a different role for glia in this model of
early in life nerve injury. In this way, microglia is a het-
erogeneous group with many functions that include sur-
veillance (resting microglia), toxicity (classical activation
associated with pro-inflammatory cytokines), neuropro-
tection (alternative activation associated with anti-
inflammatory cytokines and repair) [53-55]. Thus, it could
be possible that glia has a different role in this model
where microglia activates towards a healing process with
the astrocyte support. Our results show that microglia is
not activated after nerve injury as it would be expected for
a repair phenotype. Instead, microglia activation begins
at the onset of adult hood 3 weeks after the initial insult
and is accompanied by mechanical hypersensitivity. The
experimental models of neuropathic pain in adult clearly
show that microglia activation has pro-inflammatory
phenotype [56,57] and this activation is directly linked to
initiation of pain behaviours [13]. Thus, our results are
more in accordance with a role of microglia in triggering
mechanical hypersensitivity. Nevertheless, we consider
that further analysis is required to understand the role and
mechanisms of microglia and astrocytes activation in this
model of early in life nerve injury.To explore the neuronal mechanisms that might under-
lie this novel mechanical hypersensitivity following early
life nerve injury we have explored a classic mechanism that
underlies maintained neuropathic mechanical allodynia in
adult nerve injury models, namely NMDA mediated cen-
tral sensitization [58]. Central sensitization is a well-
established mechanism whereby dorsal horn neuronal ac-
tivity is enhanced due to increased membrane excitability
as a result of opening voltage sensitive NMDA channels
allowing Ca2+ entry into the cell [59]. Activation of NMDA
receptors is an essential step in both initiating and main-
taining activity-dependent central sensitization [60] and
the use of inhibitors such us ketamine can attenuate neuro-
pathic allodynia in adults [14,61]. In the present study, we
have clearly demonstrated that ketamine applied when the
rat reaches adulthood reverses the mechanical hypersensi-
tivity following early life nerve injury to baseline levels. The
mechanism by which this central sensitization only
emerges three weeks after P10 nerve injury is not clear, but
it is possible that it results from alterations in activity
dependent maturation of dorsal horn inhibitory circuits
[62] or descending controls of dorsal horn excitability [63].
The importance of early life events in individual dis-
ease susceptibility is well known but recognition that
early pain experience may also predispose individuals to
greater pain at a later stage of life is a more recent con-
cept. Increasing evidence of the activity dependence and
plasticity of both peripheral and central sensory connec-
tions in the neonatal period suggests that excess nocicep-
tive input or tissue injury in infancy could lead to
prolonged structural and functional alterations in pain
pathways lasting into adult life [23,64]. This is especially
relevant to individuals who have experienced significant
and repeated noxious stimulation as a result of surgery
and intensive care in infancy [11]. Such clinical procedures
evoke robust behavioural and physiological responses at
spinal cord and cortical level [4,53] causing measurable
hyperalgesia [5,6,52] and may leave a lasting susceptibility
to pain in later life [2]. The effects we report here are
restricted to early life infant nerve injury which causes no
sign of pain in the weeks, months and years after injury in
humans and the same equivalent developmental period in
rats. However, adolescence reveals a baseline hypersensi-
tivity after early in life nerve injury that is similar to that
seen in humans. Therefore, we provide a new insight to
those mechanisms that contribute to chronic pain beha-
viours such as late onset of phantom syndromes.
Conclusion
In conclusion, we report here, a novel consequence of
early life nerve injury whereby mechanical hypersensitiv-
ity only emerges later in life. This delayed adolescent
onset in mechanical pain thresholds is accompanied by
neuroimmune activation and NMDA dependent central
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http://www.molecularpain.com/content/8/1/30sensitization spinal nociceptive circuits. This delayed
onset in mechanical pain sensitivity may provide clues to
understanding the long term effects of early injury such
as late onset phantom pain and the emergence of com-
plex adolescent chronic pain syndromes.
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